Dutch trial establishes feasibility of screening approach in routine specialty care ...

Smart watches and devices are making more people aware of their irregular heartbeats. In fact, in some cases, they are leading to a common condition being diagnosed sooner: Atrial Fibrillation, ...

Oxford University-led AMALFI clinical trial results presented at the European Society of Cardiology (ESC) Congress 2025 and published in the Journal of the American Medical Association (JAMA). AMALFI ...

The FDA announced the Apple Watch atrial fibrillation (AFib) tool is qualified for use in clinical trials through its Medical Device Development Tools (MDDT) program, thus enabling researchers to use ...

- As the world’s first ring-type medical device to monitor heart signals, CART-I continually measures atrial fibrillation 24/7 - In-house developed AI technology is used to provide significant medical ...

Smartwatches with both PPG and ECG functionality improve the detection of atrial fibrillation in comparison with standard care. Researchers from Amsterdam UMC analysed the data from 437 patients and ...

AMSTERDAM -- Edoxaban (Savaysa) didn't improve outcomes for high-risk patients with subclinical atrial fibrillation (Afib)-like episodes detected by implanted cardiac devices, the NOAH-AFNET 6 trial ...

Greg Barrett, VP Marketing and Managed Markets at Daiichi Sankyo The partnership between Daiichi Sankyo and Partners HealthCare's Center for Connected Health to bring mobile device monitoring to ...